Clinical trial Recruiting at 1 site Observational

Analyzing biological samples from skull base tumors

Official title: Molecular and Cellular Characterization of Skull Base Tumors

Run by University of Pittsburgh · NCT03759717 · Data updated 2026-11-12

This study is testing how analyzing samples from skull base tumors can help identify new tumor types and improve treatment options for patients.

Quick facts

Study typeObservational
SexAll
Enrollment4000 (estimated)
SponsorUniversity of Pittsburgh
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (Pittsburgh, Pennsylvania)
StatusRecruiting
StartedOctober 3, 2018
Main results expectedOctober 3, 2028
Study endsOctober 3, 2028
Registry record updatedSeptember 25, 2026
Trial IDNCT03759717 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals diagnosed with a skull base tumor.

Probably not a fit

Patients who do not have sufficient tumor samples at the time of resection will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on the molecular and cellular characterization of skull base tumors by analyzing biological samples and genetic material. The aim is to identify new molecular features that can redefine tumor subtypes and improve patient management strategies. By comparing primary and recurrent tumors, the study seeks to uncover changes that occur after treatment, which may lead to novel chemotherapeutic options. The findings could enhance the understanding of tumor behavior and inform personalized treatment approaches.

Why it matters

Potential benefit: If successful, this study could lead to more accurate diagnoses and tailored treatment plans for patients with skull base tumors.

How similar studies have gone: While this approach is innovative, similar studies have shown promise in characterizing tumors at a molecular level, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of a skull base tumor

Exclusion Criteria:

* Insufficient tumor sample at time of resection

Where it's running

  • University of Pittsburgh Medical Center
    Pittsburgh, Pennsylvania, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.